Plastics in Medical Devices

Plastics in Medical Devices

Volumn , Issue , 2010, Pages

  Sastri, Vinny R ^a  

^a Winovia LLC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84882214910     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Book

References (353)

1. Food Drug and Cosmetic (FD&C) Act Section 201 [21 U.S.C. 32] Section h.
2. Medical Device Directive 93/42 European Economic Commission (MDD 93/42 EEC).
3. United States-FDA 21 CFR Part 860 Medical Device Classification Procedures.
4. Estrin N.F. The Medical Device Industry 1990, CRC Press, Marcel Dekker Inc, New York.
5. Squibb E.R. The collected papers of Edward Robinson Squibb, M.D., 1819-1900. Food Labeling: Toward National Uniformity 1992, 39. National Academies Press, Washington DC, USA. D. Porter, R. Earl (Eds.).
6. Federal Food and Drugs Act of 1906 (The "Wiley Act") Public Law Number 59-384 34 Stat.768 (1906) 21 U.S.C. Sec 1-15 (1934) (Repealed in 1938 by 21 U.S.C. Sec 329 (a)).
7. Study Group on Medical Devices Medical Devices: A Legislative Plan 1970, Department of Health Education and Welfare, Washington, D.C.
8. FDA Office of Compliance and Surveillance Device Recalls: A Study of Quality Problems 1990, HHS Publication FDA-90-4235, Washington DC, USA.
9. FDA Medical Device Regulation from Premarket Approval to Recall-Department of Health and Human Services Inspector General's Study, 1990.
10. 21 CFR Part 820-Quality Systems Regulation.
11. 21 CFR Parts 808, 812, 820 Medical Devices; Current Good Manufacturing Practices (CGMP); Final Rule October 7, 1996, pp. 52606, response #7.
12. Premarket Approval (PMA) - is the FDA process of scientific and regulatory review of devices "that support or sustain human life, are of substantial importance in preventing impairment of human health, or which present a potential, unreasonable risk of illness or injury".
13. 510(k) application and submission - is the FDA scientific and regulatory approval process of devices that a manufacturer thinks is "substantially equivalent" to a similar device that was on the market prior to May 28, 1976. This is less involved than the premarket approval defined in reference 9.
14. Investigational Device Exemption (IDE) is issued by the FDA to allow the use of investigational devices in human subjects for clinical trials and investigation in order to evaluate the safety and effectiveness of the investigational medical device.
15. ISO 13485:2003, Medical devices - Quality management systems - Requirements for regulatory purposes.
16. ISO 14971:2007, Medical devices - Application of risk management to medical devices.
17. ISO/TR 14969:2004, Medical devices - Quality management systems-Guidance to the application of ISO 13485:2003.
18. Ministerial Ordinance on Standards for Quality Assurance for Drugs, Quasi-drugs, Cosmetics, and Medical Devices MHLW. Ordinance Number September 22, 2004, 136.
19. Public Law 105-230, sect. 1, 112 Stat. 1519 codified in 21 U.S.C. 1601-1606, 1999.
20. Quality Management System-Medical Devices-Guidance on the Control of Products and Services Obtained from Suppliers.
21. Bennion E. Antique Medical Instruments 1979, University of California Press.
22. Luwigson D.C. Met. Eng. Q 1965, 5(3):1-6.
23. D.F. Williams, R. Roaf, In: Implants in surgery. W.B. Saunders (Ed.), 1973.
24. Bechtol C.O., Ferguson A.B., Laing P.G. Metals and Engineering in Bone and Joint Surgery 1959, The Williams and Wilkins Company.
25. Gilbert J.L. Medical Plastics and Biomaterials Magazine May 1998, 16.
26. Leventhal G.C. J. Bone Joint Surg 1951, 33:473.
27. Laing P. Orthop. Clin. North Am. 1973, 4(2):249-275.
28. Pilliar R.M. Biomaterials 1991, 12(2):95-101.
29. Handbook of materials for medical devices 2003, ASM International. J.R. Davis (Ed.).
30. Kauffman G.B., Mayo I. The Story of Nitinol: The Serendipitous Discovery of Memory Metal and Its Applications 2005, Springer.
31. Bundy K.J. Crit. Rev. Biomed. Eng 1994, 22(3-4):139-251.
32. Johnson J.L. Medical Device and Diagnostic Industry November 2002, 48.
33. Vallet-Regi M. J. Chem. Soc. Dalton Trans. 2001, 97-108.
34. De Jong W.F. Rec. Tav. Chim 1927, 45:415-448.
35. Gatti A.M., Zaffe D., Poli G.P. Biomaterials 1990, 11:513-517.
36. Richerson D.W. Modern Ceramic Engineering 2006, Academic Press, New York. third ed.
37. Suchanek W., Yoshimura M., Material Res J. Sci. 1998, 13(1):94-117.
38. Hench L.L. Ceramics: towards the 21st century 1991, 519-534. Ceram. Soc, Japan. W. Soga, A. Kato (Eds.).
39. Hench L.L., Splinter R.J., Allen W.C., Greenlee T.K. J. Biomed. Mater. Res. Symp. 1972, 2:117-141.
40. L.L. Hench, Bioceramics: materials characteristics vs. in vivo behavior, in: P. Ducheyne, J.E. Lemons (Eds.), Ann. N. Y. Acad. Sci., vol. 523, New York, 1988, pp. 54-71.
41. Rice R.W. AiChE J 2004, 36(4):481-510.
42. Utracki L.A. Polymer Alloys and Blends: Thermodynamics and Rheology 1990, Hanser.
43. Disinfection Sterilization and Preservation 2001, 25. Lippincott, Williams and Wilkins. fifth ed. S. Seymour, Block (Eds.).
44. ANSI/AAMI/ISO 17665-1:2006-Sterilization of health care products-Moist heat-Part 1. Requirements for the development, validation, and routine control of a sterilization process for medical devices.
45. AAMI/CDV-2 20857 (ISO/TC 198/DIS 20857)-Sterilization of health care products-Dry heat-Requirements for the development, validation, and routine control of a sterilization process for medical devices (Draft).
46. ANSI/AAMI/ISO 11135-1:2007-Sterilization of health care products-Ethylene oxide-Part 1: Requirements for the development, validation, and routine control of a sterilization process for medical devices.
47. ANSI/AAMI/ISO 11137-1:2006-Sterilization of health care products-Radiation-Part 1: Requirements for the development, validation, and routine control of a sterilization process for medical devices.
48. Wayne R. Steam: uses and challenges for device sterilization. Med. Dev. Diagnost. Indus March 2006, 80-87.
49. Parametric release methods for steam.
50. Daly H.B., Nguyen K.T., Sanschagrin B., Cole K.C., et al. J. Inject. Mold. Technol 1998, 2(2):59-85.
51. Mendes G.C., Brandão T.R., Silva C.L. Ethylene oxide sterilization of medical device: a review. Am. J. Infect. Control November 2007, 35(9):574-581.
52. Parker R.E., Isaacs N.S. Chem. Rev. 1959, 59:737.
53. Haines J.A., Reese C.B., Todd A.R., Chem J. Soc. London 1962, 5281.
54. Barry P. Fairand, Radiation sterilization for Healthcare 2001, Products CRC Press.
55. Charlesby A. The Effects of ionizing radiation on polymers. Radiation Effects on Polymers 1991, 39-78. Springer. D.W. Clegg, A.A. Collyer (Eds.).
56. Clough R.L., Gillen K.T., Dole M. Radiation resistance of polymers and composites. Radiation Effects on Polymers 1991, 114-134. Springer. D.W. Clegg, A.A. Collyer (Eds.).
57. D. Dhara, K. Glasgow, V. Kumar, US Patent 20070081918, April 12, 2007.
58. O. James, ANTEC Proceedings 2004, pp. 3676-3679.
59. Encyclopedia of Polymer Science and Technology 2004, vol. 2:309-310.
60. Guidance for Industry and FDA Staff-Early Development Considerations for Innovative Combination Products (September 2006).
61. FDA 21, CFR Parts 177, Indirect Food Additives: Polymers, Section 2600 Rubber Articles Intended for Repeated Use.
62. FDA Draft Guidance-Metered Dose Inhaler (MDI) and Dry Powder Inhaler (DPI) Drug Products-Chemistry, Manufacturing, and Controls Documentation (1998).
63. FDA Guidance for Industry-Nasal Spray and Inhalation Solution, Suspension and Spray Drug Products-Chemistry, Manufacturing, and Controls Documentation (2002).
64. Required Biocompatibility Training and Toxicology Profiles for Evaluation of Medical devices, May 1, 1995 (G95-1)-FDA Bluebook.
65. Strum L.C.E. Polym. Eng. Sci. 2004, 17(3):165-173.
66. Arrhenius S. Z. Phys. Chem 1889, 4:226.
67. Troughten M.J. Handbook of Plastic Joining 2008, William Andrew, USA.
68. Plastics Additives Handbook 2001, Carl Hanser Verlag. fifth ed. H. Zweifel, E. Amos (Eds.).
69. FDA 21 CFR Parts 177: Indirect Food Additives: Polymers.
70. FDA 21 CFR Parts 178: Indirect Food Additives: Adjuvants, Production Aids, Sanitizers.
71. Wallin F.R. Int. J. Toxicology 1988, 7(4):491-497.
72. FDA 21 CFR Parts 820: Quality Systems Regulations.
73. ISO 13485:2003 - Medical devices - Quality management systems - Requirements for regulatory purposes.
74. D.F. Cadogan, C.J. Howick, in: Kirk-Othmer (Ed.), Encyclopedia of Chemical Technology, vol. 19, 1996, pp. 258-290.
75. Wypych G. Handbook of Plasticizers 2004, ChemTec Publishing.
76. Rahman M., Brazel C. Prog. Polym. Sci. 2004, 29(12):1223-1248.
77. Goodman D. J. Vinyl Tech. 1994, 16(3):156.
78. Finney D.C., David R.M. Med. Plast. Biomater 1994, 2(1):48.
79. Safety Assessment of Di(2-ethylhexyl)phthalate (DEHP) Released from PVC Medical Devices, CDRH, 2002.
80. European Commission, Health and Consumer Protection Directorate General DOC.SANCO/SCMPD/2002/0010/Final.
81. Kato K. Wear 2000, 241(2):151-157.
82. Hutchings L.R., et al. Polym. Int. 2008, 57(2):163-170.
83. Owen M.J. Ind. Eng. Chem. Prod. Res. Dev. 1980, 19:97-103.
84. FDA 21 CFR Parts 70 Color Additives.
85. FDA 21 CFR Parts 71 Color Additives Petitions.
86. FDA 21 CFR Parts 73 Listing of Color Additives Exempt from Certification.
87. FDA 21 CFR Parts 74 Listing of Color Additives Subject to Certification.
88. FDA 21 CFR Parts 80 Color Additives Certification.
89. FDA 21 CFR Parts 81 General Specifications and General Restrictions for Provisional Color Additives For Use in Foods Drugs and Cosmetics.
90. Hao Z., Iqbal A. Chem. Revs 1997, 26:203-213.
91. Noor Y.M., et al. J. Mater. Process. Technol. 1994, 42(1):95-133.
92. J.B. Carroll, Sabreen, S., in: Proceedings SPE TOPCON, 2007.
93. A.C. Ruddy, in: Proceedings Medical Polymers 2004, November 2004, pp. 233-244.
94. S. Mirji et al., in: Proceedings SPE ANTEC 2008, pp. 2213.
95. D.A. Drews Jr., F.T. Parker, US Patent 5,300,048 April 5, 1994.
96. Persson C., et al. Proceedings of the Institution of Mechanical Engineers. Part H: Journal of Engineering in Medicine 2006, 220(7):787-791.
97. Mermel L.A. Ann. Intern. Med. 2000, 132(5):391-402.
98. D'Arcy N. Plastics Additives and Compounding December 2001, 3(12):12-15.
99. Gorman S.P., Jones D.S. Med. Device Manufact. Technol 2002, 97-101.
100. Mermelstein N.H. Food Technol. March 2000, 54(3):56-65.
101. Appendini P., Hotchkiss J. Innov. Food Sci. Emerg. Technol. 2002, 3(2):113-126.
102. Peterson L.R., Shantholzer C.H. Clin. Microbiol. Rev. 1992, 420-432.
103. Rupp M., et al. J. Infect. 2004, 32(8):445-450.
104. Lipp A., Lusardi G. Systemic antimicrobial prophylaxis for percutaneous endoscopic gastrostomy. Cochrane Database of Systematic Reviews 2006, (4). CD005571, doi: 10.1002/14651858.CD005571.pub2.
105. Sung J.Y., Ind J. Microbiol. Biotechnol. 1995, 15(3):152-155.
106. Huang J.C. Adv. Polym. Technol. 2003, 14(2):137-150.
107. Service R.F. Science 2000, 290(5491):425-427.
108. Pritchard G. Plastics Additives: An A-Z Reference 1998, Chapman Hall, 108-114.
109. Skotheim T.A., Reynolds J.R. Handbook of Conducting Polymers 2007, CRC Press.
110. National Materials Advisory Board A Matter of Size: Triennial Review of the National Nanotechnology Initiative 2006, National Academic Press.
111. Nanotechnology: Basic Science and Emerging Technologies 2002, Chapman Hall/CRC. M. Wilson (Ed.).
112. Maniar K.K. Polym. Plast. Technol. Eng 2004, 43(2):427-443.
113. Li J., et al. Appl. Phys. Lett. 2003, 82(15):2491-2493.
114. Balzani V., Credi A., Venturi M. Chem. A Eur. J. 2002, 8(24):5524-5532.
115. Mijatovic D., Eijkel J.C.T., van den Berg A. Science, Lab. Chip 2005, 5:492-500.
116. Soloviev M. J. Nanobiotechnol. 2007, 5(1):1-3.
117. J. Aguilo, J. Millan, R. Villa, Semiconductor conference 2001, in: CAS 2001 Proceedings International, October 2001, pp. 247-255.
118. Rieder M., et al. Clays Clay Miner 1998, 46(5):586-595.
119. Patel H.A., Somani R.S., Bajaj H.C., Jasra R.V. Bull. Mater. Sci. 2006, 29(2):133-145.
120. Bailey S.W. Crystal structures of clay minerals and their X-ray identification 1980, 1-123. Mineralogical Society, London, Monograph No. 5. G.W. Brindley, G. Brown (Eds.).
121. Yebassa D., et al. J. Appl. Polym. Sci. A Polym. Chem. 2004, 42:1310.
122. Schmidt D., Shah D., Giannelis E.P. Curr. Opin. Solid State Mater. Sci. 2002, 6:205-212.
123. Waddon A.J., Coughlin E.B. Chem. Mater. 2003, 15(24):4555-4561.
124. Phillips S.H., Haddad T.S., Tomzcak S.J. Curr. Opin. Solid State Mater. Sci. 2004, 8(1):21-29.
125. Freitas R.A. The future of nanofabrication and molecular scale devices in nanomedicine, Stud. Health Technol. Inform 2002, 80:45-59.
126. Finnigan B., et al. International J. Nanotechnol 2007, 4(5):496-515.
127. Leaversuch R. Plastics Technology October 2001, 64-69.
128. Dresselhaus M.S., Dresselhaus N., Ecklund P.C. The Science of Fullerenes and Carbon Nanotubes: Their Properties and Applications 1996, Academic Press.
129. Swinbanks D. Nature 1996, 383:562.
130. Kroto H.W., Heath J.R., O'Brien S.C., Curl R.F., Smalley R.E. Nature 1985, 318:162-163.
131. Guo T., Jin C., Smalley R.E. J. Phys. Chem. 1991, 95:4948-4950.
132. Wang C., et al. Prog. Polym. Sci. 2004, 29(11):1079-1141.
133. Iijima S., Ichhashi S., Anodo Y. Nature 1992, 356:776-778.
134. Ajayan P.M., Schadler L.S., Giannaris C., Rubio A. Adv. Mater. 2000, 12(10):750-753.
135. J.R. Calvert, et al., US Patent 5522383 June 4, 1996.
136. Rupp M.E., et al. Am. J. Infect. Control 2004, 32(8):445-450.
137. Silver S. FEMS Microbiol. Lett. 2003, 27:341-353.
138. Kumar R., Howdle S., Munstedt H. J. Biomed. Mater. Res. B Appl. Biomater. 2005, 75B(2):311-319.
139. Hong, et al., Internal Reports of Baxter Healthcare Corporation, in: Proceedings SPE ANTEC, 2000, pp. 2704.
140. Patrick S. Rapra Review Reports 2004, 15(3):3-42.
141. Plast. Additives Compound 2004, 46-49. September/October.
142. Vinhas G.M., et al. Polym. Degrad. Stabil. 2004, 86:431-436.
143. Nielsen Medical Plastics Proceedings, 2006.
144. European Pharmacopoeia, Part 1I-2, second ed., 1981 (Section VI 1.2. Plastic materials and 2.2. Plastic containers).
145. D.F. Cadogan, ECPI, Brussels, Belgium. Addcon 2002, in: the International Plastics Additives and Modifiers Conference, eighth, Budapest, Hungary, October 22-23, 2002, Plasticizers for PVC: Health and Environmental Impact (2002) 33-43.
146. Fanelli R., Zuccato E. Risks and benefits of PVC in medical applications. Bollettino Chimico Farmaceutico 2002, 141(4):282-289.
147. Joel A.T., Ted S., Tee G., Michael M., Mark R. Health risks posed by use of di-2-ethylhexyl phthalate (DEHP) in PVC medical devices: a critical review. Am. J. Indus. Med. 2001, 39(1):100-111.
148. MDDI, "THERMOPLASTICS: Polyurethane Film as an Alternative to PVC and Latex MATERIAL CHOICES", located on Medical Device Link at: (accessed September 2002). http://www.devicelink.com/mddi/archive/02/09/004a.html.
149. Dennis J. J. Pharmaceut. Sci. 2007, 96(10):2566-2581.
150. Heudorf U., Mersch-Sundermann V., Angerer E. Phthalates: toxicology and exposure. Int. J. Hyg. Environ. Health October 2007, 210(5):623-634.
151. Health Canada Expert Advisory Panel on DEHP in Medical Devices: Final Report January 11, 2002. http://www.hc-sc.gc.ca/hpb-dgps/therapeut/zfiles/english/advcomm/eap/dehp/eap-dehp-final-report-2002-jan-11_e.pdf.
152. Safety Assessment of Di(2-ethylhexyl)phthalate (DEHP) Released from PVC Medical Devices, Center for Devices and Radiological Health, U.S. Food and Drug Administration. < (undated). http://www.fda.gov/cdrh/ost/dehp-pvc.pdf%3E%3B.
153. European Commission, Health & Consumer Protection Directorate-General of The European Commission, Opinion on Medical Devices Containing DEHP Plasticised PVC; Neonates and Other Groups Possibly at Risk from DEHP Toxicity, Document: SANCO/SCMPMD/2002/0010 Final. (accessed 26.09.02). http://europa.eu.int/comm/food/fs/sc/scmp/out43_en.pdf.
154. Medical Devices Made With Polyvinyl chloride (PVC) Using the Plasticizer di-(2-Ethylhexyl)phthalate (DEHP); Draft Guidance for Industry and FDA. (accessed 06.09.02). http://www.fda.gov/cdrh/ode/guidance/1407.pdf.
155. Frequently Asked Questions Regarding PVC and DEHP in Medical Devices, HIMA. (accessed 00.04.02). http://www.advamed.org/publicdocs/faq499.pdf.
156. EUCOMED Position on the Use of Phthalate Plasticized PVC in Medical Products. (accessed 12.12.00). http://www.medicalplast.com/upload/documents/document4.pdf.
157. Hansen C.M. On predicting environmental stress cracking in polymers. Polym. Degrad. Stabil. 2002, 77:43-53.
158. Zahran A.H., Hegazy E.A., Ezz Eldin F.M. Radiat. Phys. Chem. E 1984, 32:25-26.
159. Begazy E.A., Seguchi T., Machi S. Radiation induced oxidative degradation of polyvinylchloride. J. Appl. Polym. Sci. 1981, 26:2947.
160. Clough R.L., Gillen K.T. Complex radiation degradation behavior of PVC material. Radiat. Phys. Chem. 1983, 22:527.
161. Clough R.L., Gillen K.T. Radiation-thermal degradation of PE and PVC: mechanism of synergism and dose rate effects. Radiat. Phys. Chem. 1981, 18:661.
162. Baccaro S., et al. Nucl. Instrum. Methods in Phys. Res. B 2003, 208:195-198.
163. Chapiro A. J. Chim. Phys. 1956, 53:895.
164. Vinhas G.M., Souto Maior R.M., de Almeida Y.M.B. Polym. Degrad. Stabil. 2004, 83:429-433.
165. Vinhas G.M., Souto Maior R.M., de Almeida Y.M.B., Netto B.B. Polym. Degrad. Stabil. 2004, 86:431-436.
166. Luther D.W., Linsky L.A. Improving gamma radiation resistance: medical grade, flexible PVC compounds. J. Vinyl Additive Technol. September 1996, 2(3).
167. Wang Q.I., Nagy S. Improving gamma-radiation stability of PVC - a review. J. Vinyl Additive Technol March 1999, 5(1):4-11.
168. V. Brunella, Pvc Stabilization during sterilization with electron beam, in: Proc. Medical Polymers, 2003.
169. P. McShane, B. Mayoral, D. McLaughlin, in: Proc. SPE ANTEC, 2005, pp. 3071-3074.
170. Zhao X.B., Courtney J.M. Blood response to plasticized polyvinyl chloride. Dependence of fibrinogen adsorption on plasticizer selection and surface plasticizer level. J. Mater. Sci. Mater. Med. October 2003, 14(10):905-1012.
171. X.B. Zhao, J.M. Courtney, Influence on blood of plasticized polyvinyl chloride: significance of the plasticizer. Bioengineering Unit, University of Strathclyde, Glasgow, United Kingdom Artificial Organs, 23(1) (January 1999) 104-107.
172. Faouzi M.A., et al. Int. J. Pharmaceut. 1999, 180:113-121.
173. Hanawa T., et al. Int. J. Pharmaceut. 2000, 210:109-115.
174. Kambia R., et al. Int. J. Pharmaceut. 2001, 229:139-146.
175. Jaeger R.J., Robert J.R. Nutrition 1997, 13(11):1011-1012.
176. Lappegard K.T., et al. Ann. Thorac. Surg. 2005, 79:917-923.
177. Van Tienhoven E.A.E., et al. J. Biomed. Res. A 2006, 175-182.
178. Kulshreshtha A.K. Polym. Plast. Technol. Eng. 1525-6111 1993, 32(6):551-578.
179. D. McConnell, G.M. McNally, W.R. Murphy, in: Proc. 2004 Medical Polymers, Dublin, Ireland, November 2004, pp. 125-142.
180. K.G. Chandan, in: Proc. Plastics in Healthcare, SPE, February 2002, pp. 30-32.
181. F.J. Karol, F.I. Jacobson, Catalytic polymerization of olefins, in: Proceedings on Future Aspects of Olefin Polymerization, Tokyo, Japan, 1985, pp. 323-338.
182. Kaminsky W., Laban A. Appl. Catal. A 2001, 222:47-61.
183. Kaminsky W. Chemosphere 2001, 43:33-38.
184. Brubeck R.A. Mater. Sci. Eng 2002, R39:1-28.
185. Rau A., Schmitz S., Luft G. Chem. Eng. Technol. 2002, 25(5):494-498.
186. Sinn H., Kaminsky W., Vollmer H.J., Woldt R. Angew. Chem. 1980, 92:396.
187. A. Lustiger, in: Robert C. Portnoy (Ed.), Medical Plastics - Degradation and Failure Analysis, 1998, pp. 65-72.
188. L. Navarette, N. Hermanson, in: Proc. SPE ANTEC, 1996, pp. 2807-2818.
189. Costa L., Bracco P. Mechanism of cross linking and oxidative degradation of UHMWPE. The UHMWPE Handbook: Ultra-high Molecular Weight Polyethylene in Total Joint Replacement 2004, 235-261. Academic Press, (Chapter 11). S. Kurtz (Ed.).
190. Jahan M.S., McKinney K.S. Nucl. Instrum. Methods Phys. Res. B 1999, 151:207-212.
191. Mallegol D., Carlsson D.J., Deschenes L. Nucl. Methods Instrum. Phys. Res. B 2001, 85:283-293.
192. Suarez J.C.M., De Biasi R.S. Polym. Degrad. Stabil. 2003, 11(82):221-227.
193. Affatato S., et al. Tribol. Int 2008, 41:813-822.
194. Affatato S., et al. Biomaterials 2003, 24:4045-4055.
195. Shang S., et al. J. Vinyl Additive Technol. 1998, 4(1):60-64.
196. Oral E., et al. Biomaterials 2005, 26(6):657-666.
197. Mallégol J., Carlsson D.J., Deschênes S. J. Polym. Degrad. Stabil. 2001, 73:269.
198. Paola Taddei Affatato Saverio, Rocchi Mirko, Fagnano Concezio, Viceconti Marco. J. Mol. Struct. 2008, 875:254-263.
199. Y.S. Liao, D. McNulty, M. Hanes, Wear 255 (August-September 2003) 1051-1056.
200. Santavirta S., et al. Clin. Orthop. Rel. Res. 1993, 297:100-110.
201. Marie-Claire B., Yves Marois J. Biomed. Mater. Res. Part B Appl. Biomater. 2001, 58(5):467-477.
202. Reno F., Lombardi F., Cannas M. Biomaterials 2003, 24:2895-2900.
203. Takami Y., Nakazawa T., Makinouchi K., et al. J. Biomed. Mater. Res. 1997, 36(3):381-386.
204. Cosmetic Ingredient Review Expert Panel. Int. J. Toxicol 2007, 26(Suppl. 1):115-127.
205. Kazuo S., Takeshi S. Ziegler-Natta catalysts for olefin polymerizations. Prog. Polym. Sci. 1997, 22(7):1503-1546.
206. Galli P., Vecellio G. Prog. Polym. Sci. 2001, 26:1287-1336.
207. De Rosa C., Auriemma F. Prog. Polym. Sci. 2006, 31:145-237.
208. Kaminsky W. J. Chem. Soc. Dalton Trans 1998, 1413-1418.
209. Kaminsky W. Pure Appl. Chem. 1998, 70(6):1229-1233.
210. Libster D., Aserin A., Garti N. Polym. Adv. Technol. 2007, 18:685-695.
211. Albano C., Perera C., Karam A., et al. Beam interactions with materials and atoms, Nucl. Instrum. Methods Phys. Res. B December 2007, 265(1):265-270.
212. Yagoubi N., Boucherie P., Ferrier D. Nucl. Instrum. Methods Phys. Res. B 1997, 131:398-404.
213. Alariqi S.A.S., et al. Polym. Degrad. Stabil. 2007, 92(2):99-309.
214. Aymes-Chodur C. Polym. Degrad. Stabil. 2006, 91:649-662.
215. Ahmad S. Polym. Additives Compound May/June 2005, 38-45.
216. Matthijs, Medical Polymers, 2004.
217. Shamshad A., Basfar A.A. Radiat. Phys. Chem. 2000, 57:447-450.
218. Elvidio de Paula E.S., Everton L.S.R., Sérgio V.B. Braz. Dent. J. 2001, 12(2):121-125.
219. Scheidbach H., et al. Surg. Endosc. 2004, 18:211-220.
220. Jones J.W., Jurkovich G.J. Polypropylene mesh closure of infected abdominal wounds. Am. Surg. 1989, 55:73-76.
221. Van Der Velden M.A., Klein W.R. A modified technique for implantation of polypropylene mesh for the repair of external abdominal hernias in horses: a review of 21 cases, Vet. Quart. 1994, 16:108-110.
222. Anderson A.W., Merckling N.G. U.S. Patent 1955, 2(721):189.
223. Anderson A.W., Merckling N.G. Chem. Abstr. 1955, 50:3008.
224. Dragutan V., Balban A.T., Dimonie M. Olefin Metathesis and Ring-Opening Polymerization of Cyclo-Olefins 1985, Wiley, New York.
225. Pariya C., Jayaprakash K.N., Sarkar A. Coord. Chem. Rev. 1998, 168:1-48.
226. Nielsen T.B., Hansen C.M. Polym. Degrad. Stabil. 2005, 89(3):513-516.
227. N.J. Hermanson, L. Navarette, P. Crittenden, Medical Device and Diagnostic Industry, August 1997.
228. P.D. Colburn, in: Proceedings Medical Plastics, vol. 17, 2003, pp. C5.1-C5.9.
229. D. Zimmerman, IAPD Magazine June/July 2002.
230. M. Vlug, in: Proceedings Medical Plastics, Hexagon Holding APs, 2004.
231. M. Hernandez-Valdez, et al., in: Proceedings of SPE ANTEC 2005, pp. 3083-3086.
232. F. Mehlmann, Proceedings Medical Grade Polymers 2008, AMI Plastics, Philadelphia, Pennsylvania, 2008.
233. Hermanson N.J., Crittenden P.A., Novak L.R., Woods R.A. Medical plastics: degradation and failure analysis. Plastics Design Library 1998, 117-122. Norwich, New York. R.C. Portnoy (Ed.).
234. Bayer Polycarbonate Brochure - Markrolon - pdf files.
235. Kjelllander C.K., et al. Polym. Degrad. Stabil. 2008, 93(8):1486-1495.
236. Al-Saidi L.F., Mortensen K., Almdal K. Polym. Degrad. Stabil. 2003, 82(3):451-461.
237. Lundy C. J. Appl. Med. Polym. 1997, 1(1):35-38.
238. J.Y.J. Chung, in: Proceedings Annual Technical Conference, ANTEC, 1996, pp. 2784-2788.
239. George A., Pitt W.G. Biomaterials 2002, 23:1369-1373.
240. M.D.M. Evans, sb:et al., 23(2002) 1359-1367.
241. K. Scott, in: Proceedings Processing Pharmaceutical Polymers, Basel, Switzerland, 2007.
242. Salzman E.W., Merrill E.W., Kent K.C. Hemostasis and thrombosis: basic principles and clinical practice 1994, 1469. J.B. Lippincott Co., Philadelphia. third ed. R.W. Colman, J. Hirsh, V.J. Marder, E.W. Salzman (Eds.).
243. Tirrell M., Kokkoli E., Biesalski M. Role of surface science in bioengineered materials. Surf. Sci. 2002, 500:61-83.
244. Ikada Y. Surface modification of polymer for medical applications. Biomaterials 1994, 15:25-36.
245. Sen Gupta A., et al. Biomaterials 2006, 27:3084-3095.
246. NTP-CERHR Monograph on the Potential Human Reproductive and Developmental Effects of Bisphenol A September 2008 NIH Publication No. 08 - 5994 and all references therein.
247. McLean R.S., Sauer B.B. Macromolecules 1997, 30:8314-8317.
248. I. Révenko, Y. Tang, in: 25th Annual Meeting Transactions, Society for Biomaterials, Providence, Rhode Island, USA, 1999, p. 354.
249. Khan I., et al. Biomaterials 2005, 26:621-631.
250. Qin C. J. Appl. Med. Polym. 1998, 2(1):24-28.
251. Terheyden H., et al. Br. J. Oral Maxillofac. Surg. 2000, 38:299-304.
252. Dow Chemical Tech. Note - Form 301-02668-696.
253. Abraham G.A., Frontini P.M., Cuadrado T.R. Polym. Sci. 1997, 65(6):1193-1203.
254. Zhang Y.Z., et al. Biomaterials 1996, 17:2265-2272.
255. Yuan Y., et al. Colloids Surf. B Biointerfaces 2004, 35:1-5.
256. Poussard L., et al. Biomaterials 2004, 25:3473-3483.
257. Silver J.H., Karayianni E., Cooper S.L. J. Colloid Interface Sci. 1996, 178:219-232.
258. Keogh J.R., et al. Biomaterials 1996, 17:1987-1994.
259. Santerre J.P. Biomaterials 2005, 26:7457-7470.
260. Stokes K., McVennes R. Polyurethane elastomer biostability. J. Biomater. Appl. 1995, 9:321-335.
261. Phillips R.E., Smith M.C., Thoma R.J. Biomedical applications of polyurethanes: implications of failure mechanisms. J. Biomater. Appl. 1988, 3:207-227.
262. Hsu S.H., Lin Z.C. Colloids Surf. B Biointerfaces 2004, 36:1-12.
263. DuPont, Delrin Design Information Module III, p. 32.
264. E. Bjorklund, in: Proceedings Medical Plastics 2006, Copenhagen, Denmark, 2006.
265. McIlvaine J.E. J. Appl. Med. Polym. 1998, 2(1):10-13.
266. G.M. Stack, K. Breeding, in: Proceedings ANTEC, 2007, pp. 1657-1661.
267. Xue L., Greisler H.P. J. Vasc. Surg. 2003, 37(2):472-480.
268. Seitz H., et al. Biomaterials 1998, 18:189-196.
269. H. Gappa-Fahlenkamp, R.S. Lewis, 26 (2005) 3479-3485.
270. Wang J., et al. Surf. Coat. Technol. 2005, 196:307-311.
271. P. Anthony, in: Proceedings Medical Plastics, Hexagon Holdings, Copenhagen, Denmark, 2002.
272. S. Inari, in: Proceedings Medical Plastics, Hexagon Holdings, Copenhagen, Denmark, 2003/2004.
273. T. Sammut, E. Moskala, in: Proceedings Medical Polymers, Dublin, Ireland, 2004, pp. 169-199.
274. L. Navarrette, N. Hermanson, in: Proceedings ANTEC, 1996, pp. 2806-2818.
275. Taub M., et al. Injury. Int. J. Care Injured 2004, 35:878-882.
276. J. McIlvaine, in: Conference Proceedings, Annual Technical Conference ANTEC, vol. 3, 1995, pp. 3346-3349.
277. Singhal J.P., Ray A.R. Biomaterials 2002, 23:1139-1145.
278. Risbud M.V., Bhonde R.R. J. Biomater. Sci. Polym. Edit. 2001, 12(1):125-136.
279. Johnson R.N., Farnham A.G., Clendinning R.A., et al. J. Polym. Sci. 1967, (5):2375. (Part A-1).
280. Hale W.F., Farnham A.G., Johnson R.N., Clendinning R.A. J. Polym. Sci. 1967, (5):2399. (Part A-1).
281. Johnson R.N., Farnham A.G. J. Polym. Sci. 1967, (5):2415. (Part A-1).
282. Radel® Design Guide version 3.2, Advanced Polymers, Solvay.
283. Brown J.R., O'Donnell J.H. J. Appl. Polym. Sci. 1979, 23:2763.
284. Brown J.R., O'Donnell J.H. J. Appl. Poly. Sci. 1975, 19:405.
285. Udel® Design Guide version 2.1, Advanced Polymers, Solvay.
286. Kowal J., Czajkowska B., Bulwan E., Blazewicz M., Pamula E. European Cells and Materials 2004, 7(Suppl. 1):59.
287. Hoenich N.A., Katopodis K.P. Biomaterials 2002, 23:3853-3858.
288. White D.M., Takekoshi T., Williams F.J., Rekkes H.M., Donahue P.E., Webber M.J. J. Polym. Sci. 1981, 19:1635. (Part A).
289. D.B. Nazareth, S.M. Cooper, Medical plastics degradation and failure analysis, in: R.C. Portnoy (Ed.), Plastics Design Library, 1998, 157-165.
290. J.-P. Bonnadier, Proceedings Medical Polymers, Dublin, Ireland, November 2004, 13-33.
291. Peluso G., Petillo O., Ambrosio L., Nicolais L. J. Mater. Sci. Mater. Med. 1994, 5:738-742.
292. Tao C.T., Young C.H. J. Memb. Sci. 2006, 269:66-74.
293. Torlon® Design Guide, Advanced Polymers T-50246 D 03/07, Solvay 2007.
294. Srinivasan, et al., Proceedings INTC_TAPPI September 6, 2001.
295. Tanthapanichakoon W., et al. Polym. Degrad. Stab. 2006, 91:2614-2621.
296. Massey L.K. The Effects of Sterilization Methods of Plastics and Elastomers 2005, William Andrew.
297. Advanced Polymers Technical Bulletin KT-50549 R 10/07, Solvay.
298. I. Sinz, S. Green, Proceedings Medical Plastics 2003, Copenhagen, Denmark, October 2003.
299. PEEK CLASSIX_Polymer_Brochure.pdf. http://www.invibio.com/documents/BROCHURE%2013.
300. Williams D.F., McNamara A., Turner R.M. J. Mater. Sci. Lett. 1987, 6:188.
301. Toth J.M., Wang M., Estes B.T., Scifert J.L., Seim H.B., Turner A.S. Attachment and proliferation of osteoblasts and fibroblasts on biomaterials for orthopaedic use. Biomaterials 2006, 27(3):324-334.
302. G. Stuart, G. Roland, C. Keith, T. Roger, Proceedings Medical Plastics 2005, Copenhagen, Denmark, October 2005.
303. A. Hunter, C.W. Archer, P.S. Walker, G.W. Blunn 16(4) 1995 287-295.
304. Katzer, et al. Biomaterials 2002, 23:1749-1759.
305. H.C. Linstid, A. Kaslusky, C.E. McChesney, M. Turano, NPE 2000, Chicago, IL, 20 June, 2000.
306. Forsythe J.S., Hill D.J.T. Prog. Polym. Sci. 2000, 25:101-136.
307. Florin R.E. Radiation chemistry of fluorocarbon polymers. Fluoropolymers 1972, 317-380. Wiley, New York. L.A. Wall (Ed.).
308. Lappan U., Hausler L., Pompe G., Lunkwitz K. J. Appl. Polym. Sci. 1997, 66:2287-2291.
309. Fayolle B., Audouin L., Verdu J. Polymer 2003, 44:2773-2780.
310. Chen M., Zamora P.O., Som P., et al. J. Biomater. Sci. 2003, 14(9):917-935. Polym. Ed.
311. Bhat V.D., Klitzman B., Koger K., Truskey G.A., Reichert W.M. J. Biomater. Sci. 1998, 9:1117. Polym. Ed.
312. Modern Styrenic Polymers: Polystyrene and Styrenic Copolymers 2003, John Wiley & Sons. J. Scheirs, D. Priddy (Eds.).
313. T.B. Nielsen, C.M. Hansen, in: Proceedings Medical Plastics 2002, Hexagon Holdings ApS, Copenhagen, Denmark, August 2002.
314. C. Qin, S.Y.P. Ding, H. Dhyani, K.Z. Hong, M. Monaghan, V. Zepchi, L. Woo, in: Proceedings SPE ANTEC, 1998.
315. Navarrette L., Hermanson N. Medical plastics: degradation resistance and failure analysis 1998, 51-64. R.C. Portnoy, W. Andrew (Eds.).
316. Medical Applications of K-Resin SBC Chevron Phillips Technical Service Memorandum #292, 2001.
317. Hermanson N., Navarrette L., Crittenden P. Medical Device and Diagnostic Industry August 1997, 101.
318. R.T. Kingsbury, in: Proceedings ANTEC 1991, Montreal, May 1991.
319. Terheyden H., Lee U., Ludwig K., Kreusch T., Hedderich J. Br. J. Oral Maxillofac. Surg 2000, 38:299-304.
320. Bondurant S., Ernster V., Herdman R. Safety of Silicone, Breast Implants Institute of Medicine 2000, National Academy Press, Washington, DC.
321. P. Schoen, in: Proceedings Medical Plastics 2002, vol. 16, Hexagon Holding ApS, Copenhagen, Denmark, 2002, pp. 20.1-20.11.
322. D. Schultze, in: Proceedings Medical Plastics 2005, Hexagon Holdings ApS, Copenhagen, Denmark, 2005.
323. Hytrel Thermoplastic Polyester Elastomer Design Information Module V DuPont Engineering Polymers H-38344 09-98.
324. Vroman I., Tighzert L. Materials 2009, 2:307-344.
325. Congress U.S. Office of Technology Assessment, Biopolymers: Making Materials Nature's Way-Background Paper, OTA-BP-E-102 September 1993, U.S. Government Printing Office, Washington, DC.
326. C.C. Chu, The biomedical engineering handbook, in: L.D. Bronzio (Ed.), CRC Press, Boca Raton, Florida, 1995 (Chapter 44); W. Amass, A. Amass, B. Tighe, Polym. Int. 47 (1999) 89-144.
327. ANSI-ASTM Definitions (ASTM Standardization News December 1999).
328. Mohanty A., Misra M., Hinrichsen G. Macromol. Mater. Eng 2000, 276-277.
329. Chandra R., Rustgi R. Biodegradable polymers, Prog. Polym. Sci. 1998, 23:1273-1335.
330. Ikada Y., Tsuji H. Macromol. Rapid Commun 2000, 21:117-132.
331. Martin D.P., Williams S.F. Biochem. Eng. J. 2003, 16:97-105.
332. Drumright R.E., Gruber P.R., Henton D.E. Adv. Mater 2000, 12:1841-1846.
333. Hartmann M.H. Biopolymers from Renewable Resources 1998, 367-411. Springer-Verlag, Berlin, Heidelberg. D.L. Kaplan (Ed.).
334. Lunt J., Shafer A.L., Ind J. Text 2000, 29:191-205.
335. Krebs H., Hems R., Weidemann M., Speake R. Biochem. J. 1966, 101:242-249.
336. Rozema F.R., van Aasten J.A.A.M., Bos R.R.M., Boering G., Nijenhuis A.J., Pennings A.J. J. Appl. Biomater 2009, 2(1):23-28.
337. Weira N.A., Buchanana F.J., Orra J.F., Farrarb D.F., Boyd A. Biomaterials 2004, 25:3939-3949.
338. Plikk P., Odelius K., Hakkarainen M., Albertsson A.C. Biomaterials 2006, 27:5335-5347.
339. Ho K.L.G., Pometto A.L., Environ J. Polym. Degrad 1999, 7(2):93-100.
340. Mitomo H., Watanabe Y., Yoshii F., Makuuchi K. Radiat. Phys. Chem. 1995, 46(2):233-238.
341. Luo S., Netravalli A.N. J. Appl. Polym. Sci. 1999, 73:1059-1067.
342. Holy C.E., Cheng C., John E., Davies J.E., Shoichet M.S. Biomaterials 2001, 22:25-31.
343. Cottam E., Hukins D.W.L., Lee K., Hewitt C., Jenkins M.J. Med. Eng. Phys. 2009, 31:221-226.
344. Darwis D., Mitimo H., Enjoji T., Yoshii F., Makuuchi K. Polym. Degrad. Stab 1998, 62:259-265.
345. Anderson J.M., Shive M. Adv. Drug Deliv. Rev. 1997, 28:5-24.
346. S. Gogolewski, in: Proceedings Medical Plastics 2005, Hexagon Holdings ApS, Copenhagen, Denmark, 2005.
347. Chen G.Q., Wu Q. Biomaterials 2005, 26:6565-6578.
348. Yang X.S., Zhao K., Chen G.Q. Biomaterials 2002, 23:1391-1397.
349. Wang Y.W., Wu Q., Chen G.Q. Biomaterials 2003, 24:4621-4629.
350. Doyle C., Tanner E.T., Bonfield W. Biomaterials 1991, 12:841-847.
351. Okada H., Toguchi H. Crit. Rev. Ther. Drug Carrier Syst 1995, 12:1-99.
352. Grizzi I., Garreau H., Li S., Vert M. Biomaterials 1995, 16:305-311.
353. Salerni C. Medical Device And Diagnostic Industry June 2000, 90.